These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 9706431)

  • 1. Ototoxicity due to hydroxychloroquine: report of two cases.
    Johansen PB; Gran JT
    Clin Exp Rheumatol; 1998; 16(4):472-4. PubMed ID: 9706431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxychloroquine-induced ototoxicity in a child with systemic lupus erythematosus.
    Lim SC; Tang SP
    Int J Rheum Dis; 2011 Feb; 14(1):e1-2. PubMed ID: 21303469
    [No Abstract]   [Full Text] [Related]  

  • 3. Hydroxychloroquine ototoxicity in a patient with systemic lupus erythematosus.
    Fernandes MRN; Soares DBR; Thien CI; Carneiro S
    An Bras Dermatol; 2018 Jun; 93(3):469-470. PubMed ID: 29924251
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hydroxychloroquine-induced hearing loss: First case of positive rechallenge and analysis of the French pharmacovigilance database].
    Chatelet JN; Auffret M; Combret S; Bondon-Guitton E; Lambert M; Gautier S
    Rev Med Interne; 2017 May; 38(5):340-343. PubMed ID: 27745936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxychloroquine ototoxicity in a patient with rheumatoid arthritis.
    Seçkin U; Ozoran K; Ikinciogullari A; Borman P; Bostan EE
    Rheumatol Int; 2000; 19(5):203-4. PubMed ID: 10984140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxychloroquine ototoxicity in a child with idiopathic pulmonary haemosiderosis.
    Coutinho MB; Duarte I
    Int J Pediatr Otorhinolaryngol; 2002 Jan; 62(1):53-7. PubMed ID: 11738695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic efficacy and adverse events of hydroxychloroquine administration in Japanese systemic/cutaneous lupus erythematosus patients.
    Kishi C; Motegi SI; Yasuda M; Ishikawa O
    J Dermatol; 2018 Aug; 45(8):1020-1022. PubMed ID: 30133802
    [No Abstract]   [Full Text] [Related]  

  • 8. Chloroquine and hydroxychloroquine ototoxicity; potential implications for SARS-CoV-2 treatment. A brief review of the literature.
    De Luca P; Scarpa A; De Bonis E; Cavaliere M; Viola P; Gioacchini FM; Ralli M; Ettore C; Claudia C
    Am J Otolaryngol; 2021; 42(5):102640. PubMed ID: 33780902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapsed hydroxychloroquine induced thrombocytopenia in a systemic lupus erythematosus patient.
    Antón Vázquez V; Pascual L; Corominas H; Giménez Torrecilla I
    Reumatol Clin; 2017; 13(5):294-296. PubMed ID: 27263963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early cutaneous eruptions after oral hydroxychloroquine in a lupus erythematosus patient: A case report and review of the published work.
    Matsuda T; Ly NTM; Kambe N; Nguyen CTH; Ueda-Hayakawa I; Son Y; Okamoto H
    J Dermatol; 2018 Mar; 45(3):344-348. PubMed ID: 29239026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspected hydroxychloroquine-associated QT-interval prolongation in a patient with systemic lupus erythematosus.
    Morgan ND; Patel SV; Dvorkina O
    J Clin Rheumatol; 2013 Aug; 19(5):286-8. PubMed ID: 23872551
    [No Abstract]   [Full Text] [Related]  

  • 12. New clinical and ultrastructural findings in hydroxychloroquine-induced cardiomyopathy--a report of 2 cases.
    Soong TR; Barouch LA; Champion HC; Wigley FM; Halushka MK
    Hum Pathol; 2007 Dec; 38(12):1858-63. PubMed ID: 18061791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of hydroxychloroquine on cutaneous vasculitis in a Japanese patient with systemic lupus erythematosus.
    Kibune N; Shimomura Y; Hasegawa A; Saeki T; Umemori Y; Abe R
    J Dermatol; 2017 Apr; 44(4):e52-e53. PubMed ID: 27569899
    [No Abstract]   [Full Text] [Related]  

  • 14. Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus.
    Momose Y; Arai S; Eto H; Kishimoto M; Okada M
    J Dermatol; 2013 Feb; 40(2):94-7. PubMed ID: 23216212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydroxychloroquine-induced pigmentation in two patients with systemic lupus erythematosus.
    Reynaert S; Setterfield J; Black MM
    J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):487-8. PubMed ID: 16643169
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chloroquine cardiotoxicity in long-term lupus therapy in two patients].
    Saussine A; Loriot MA; Picard C; Lecerf V; Landry J; Scheer I; Voicu S; Leenhardt A; Ducrocq G; Maubec E; Crickx B
    Ann Dermatol Venereol; 2009; 136(6-7):530-5. PubMed ID: 19560616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydroxychloroquine-induced seizure in a patient with systemic lupus erythematosus.
    Malcangi G; Fraticelli P; Palmieri C; Cappelli M; Danieli MG
    Rheumatol Int; 2000 Dec; 20(1):31-3. PubMed ID: 11149659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine-induced toxic hepatitis in a patient with systemic lupus erythematosus: a case report.
    Abdel Galil SM
    Lupus; 2015 May; 24(6):638-40. PubMed ID: 25424894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxychloroquine myopathy.
    Richards AJ
    J Rheumatol; 1998 Aug; 25(8):1642-3. PubMed ID: 9712114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxychloroquine-induced phospholipidosis in a case of SLE: the wolf in zebra clothing.
    Khubchandani SR; Bichle LS
    Ultrastruct Pathol; 2013 Apr; 37(2):146-50. PubMed ID: 23573895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.